<?xml version="1.0" encoding="UTF-8"?>
<ref id="B101-viruses-12-00518">
 <label>101.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Kwon</surname>
    <given-names>Y.M.</given-names>
   </name>
   <name>
    <surname>O</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y.J.</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>B.Z.</given-names>
   </name>
   <name>
    <surname>Compans</surname>
    <given-names>R.W.</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>S.M.</given-names>
   </name>
  </person-group>
  <article-title>Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection</article-title>
  <source>Antivir. Res.</source>
  <year>2013</year>
  <volume>99</volume>
  <fpage>328</fpage>
  <lpage>335</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.06.010</pub-id>
  <pub-id pub-id-type="pmid">23811283</pub-id>
 </element-citation>
</ref>
